LETTER
General Access to 5H-Benzo[b]carbazole-6,11-diones
3109
L. A.; Estevez, J. C.; Estevez, R. J.; Castedo, L. Tetrahedron
2002, 58, 3015. (d) Cruces, J.; Estevez, J. C.; Castedo, L.;
Estevez, R. J. Tetrahedron Lett. 2001, 42, 4825.
In summary, we report here a novel nitro-group mediated
6-exo-dig regiocontrolled heteroannulation of 2-[2-(phe-
nylethynyl)phenyl]acetic acids to (Z)-1-(2-nitroben-
zylidene)isochroman-3-ones, which should be of general
interest. These complex lactones proved to be suitable
starting materials for general access to highly functional-
ized 5H-benzo[b]carbazole-6,11-diones.
(e) Estevez, J. C.; Estevez, R. J.; Castedo, L. Tetrahedron
Lett. 1993, 34, 6479. For other recent contributions, see:
(f) Liegault, B.; Lee, D.; Huestis, M. P.; Stuart, D. R.;
Fagnou, K. J. Org. Chem. 2008, 73, 5022. (g) Mal, D.;
Senapati, B. K.; Pahari, P. Tetrahedron 2007, 63, 3768.
(h) Miguel del Corral, J. M.; Castro, M. A.; Gordaliza, M.;
Martin, M. L.; Gamito, A. M.; Cuevas, C.; San Feliciano, A.
Bioorg. Med. Chem. 2006, 14, 2816. (i) Bernardo, P. H.;
Chai, C. L. L.; Heath, G. A.; Mahon, P. J.; Smith, G. D.;
Waring, P.; Wilkes, B. A. J. Med. Chem. 2004, 47, 4958.
(9) All new compounds gave satisfactory analytical and
spectroscopic data. Selected physical and spectroscopic data
follow. Compound 6a: oil; IR (NaCl): 3282 (C≡CH), 2106
(C≡C), 1736 (C=O) cm–1; 1H NMR (CDCl3): d = 3.29 (s,
1 H, CH), 3.52 (s, 2 H, CH2), 3.66 (s, 3 H, OCH3), 3.85 (s,
3 H, OCH3), 6.82 (d, J = 8.5 Hz, 1 H, ArH), 7.21 (dd, J = 8.5
Hz, 1 H, ArH), 7.35 (d, J = 2.0 Hz, 1 H, ArH); 13C NMR
(CDCl3): d = 39.8 (CH2), 52.0 (OCH3), 55.8 (OCH3), 80.0
(CH), 81.2 (C), 110.6 (ArH), 111.1 (Ar), 125.9 (Ar), 131.0
(ArH), 134.7 (ArH), 159.6 (Ar), 171.8 (C=O); MS:
Work is currently in progress on a systematic study of this
kind of alkyne heteroannulation in order to further estab-
lish its scope and limitations prior to its application to the
preparation of wide sets of 5H-benzo[b]carbazole-6,11-
diones and related compounds, including ellipticine and
analogues with powerful antitumoral properties.13,14
Acknowledgment
We thank the Spanish Ministry of Science and Education and Xunta
de Galicia for financial support, and the latter for a grant to F.J.R.
Additional thanks are given to FONDECYT (Research Grants
11085027 and 1060592) for financial support.
m/z (%) = 205 (100) [M + 1]+. Compound 6b: mp 81–83 °C
(CH2Cl2–MeOH); IR (NaCl): 3250 (CºCH), 2070 (CºC),
1722 (C=O) cm–1; 1H NMR (CDCl3): d = 3.24 (s, 1 H, CH),
3.69 (s, 3 H, OCH3), 3.79 (s, 2 H, CH2), 3.85 (s, 3 H, OCH3),
3.87 (s, 3 H, OCH3), 6.79 (s, 1 H, ArH), 6.98 (s, 1 H, ArH);
13C NMR (CDCl3): d = 38.4 (CH2), 51.3 (OCH3), 55.2
(OCH3), 55.3 (OCH3), 79.8 (CH), 81.3 (C), 112.1 (ArH),
113.6 (Ar), 114.3 (ArH), 129.4 (Ar), 147.1 (Ar), 149.1 (Ar),
171.0 (C=O); MS: m/z (%) = 235 (100) [M + 1]+. Compound
7a: mp 87–88 °C (CH2Cl2–MeOH); IR (NaCl): 2205 (C≡C),
1725 (C=O), 1565 (NO2), 1344 (NO2) cm–1; 1H NMR
(CDCl3): d = 3.70 (s, 3 H, OCH3), 3.83 (s, 3 H, OCH3), 3.94
(s, 2 H, CH2), 6.83 (d, J = 8.5 Hz, 1 H, ArH), 6.86 (s, 1 H,
ArH), 7.43 (t, J = 8.5 Hz, 1 H, ArH), 7.546 (m, 2 H, 2 ×
ArH), 7.70 (d, J = 9.1 Hz, 1 H, ArH), 8.08 (d, J = 8.2 Hz, 1
H, ArH); 13C NMR (CDCl3): d = 40.2 (CH2), 52.6 (OCH3),
55.8 (OCH3), 87.7 (C), 96.1 (C), 113.5 (ArH), 115.3 (Ar),
116.1 (ArH), 119.6 (Ar), 125.2 (ArH), 128.6 (ArH), 133.3
(ArH), 134.8 (ArH), 134.9 (Ar), 139.1 (Ar), 160.9 (Ar),
171.9 (C=O); MS: m/z (%) = 326 (53) [M + 1]+, 207 (100).
Compound 7b: mp 142–145 °C (CH2Cl2–MeOH); IR
(NaCl): 2201 (C≡C), 1724 (C=O), 1565 (NO2), 1337 (NO2)
cm–1; 1H NMR (CDCl3): d = 3.71 (s, 2 H, CH2), 3.92 (s, 6 H,
2 × OCH3), 3.94 (s, 3 H, OCH3), 6.84 (s, 1 H, ArH), 7.08 (s,
1 H, ArH), 7.46 (t, J = 7.3 Hz, 1 H, ArH), 7.60 (t, J = 7.3 Hz,
1 H, ArH), 7.73 (d, J = 7.3 Hz, 1 H, ArH), 8.09 (d, J = 7.3
Hz, 1 H, ArH); 13C NMR (CDCl3): d = 39.2 (CH2), 52.1
(OCH3), 55.9 (OCH3), 56.0 (OCH3), 87.7 (C), 95.7 (C),
112.6 (ArH), 114.6 (ArH), 118.9 (Ar), 124.7 (ArH), 128.2
(ArH), 130.5 (Ar), 132.8 (ArH), 134.4 (ArH), 147.8 (Ar),
148.8 (Ar), 150.2 (Ar), 171.7 (Ar), 179.2 (C=O); MS: m/z
(%) = 356 (0.6) [M + 1]+, 17 (100). Compound 1a: mp 152–
154 °C (CH2Cl2); IR (NaCl): 2204 (CºC), 1703 (C=O), 1564
(NO2), 1337 (NO2) cm–1; 1H NMR (acetone-d6): d = 3.85 (s,
3 H, OCH3), 3.97 (s, 2 H, CH2), 6.93 (dd, J = 8.8, 2.5 Hz, 1
H, ArH), 7.03 (d, J = 2.5 Hz, 1 H, ArH), 7.48 (t, J = 7.3 Hz,
1 H, ArH), 7.63 (t, J = 7.3 Hz, 1 H, ArH), 7.77 (m, 2 H,
ArH), 8.10 (d, J = 7.3 Hz, 1 H, ArH); 13C NMR (acetone-d6):
d = 41.0 (CH2), 56.8 (OCH3), 89.3 (C), 97.3 (C), 114.6
(ArH), 116.6 (Ar), 118.0 (ArH), 120.3 (Ar), 126.5 (ArH),
130.7 (ArH), 134.0 (Ar), 135.1 (ArH), 135.8 (ArH), 136.3
(ArH), 141.5 (Ar), 162.6 (Ar), 173.1 (C=O); MS: m/z (%) =
312 (22) [M + 1]+, 282 (100). Compound 1b: mp 163–
165 °C (CH2Cl2); IR (NaCl): 2204 (C≡C), 1710 (C=O), 1566
References and Notes
(1) (a) Huang, Q.; Larock, R. C. Org. Lett. 2002, 4, 2505.
(b) Larock, L. C. Pure Appl. Chem. 1999, 71, 1435.
(2) (a) Hiroya, K.; Suzuki, N.; Yasuhara, A.; Egawa, Y.;
Kasano, A.; Sakamoto, T. J. Chem. Soc., Perkin Trans. 1
2000, 4339; and references cited therein. (b) Zhang, H.;
Larock, R. C. J. Org. Chem. 2002, 67, 9318. (c) Kirsch, G.;
Hesse, S.; Comel, A. Curr. Org. Synth. 2004, 1, 47.
(d) Reboredo, F. J.; Treus, M.; Estévez, J. C.; Castedo, L.;
Estévez, R. J. Synlett 2003, 1603.
(3) Larock, R. C.; Yum, E. K.; Refvick, M. D. J. Org. Chem.
1998, 63, 7652.
(4) (a) Mehta, S.; Waldo, J. P.; Larock, R. C. J. Org. Chem.
2009, 74, 1141. (b) Le Bras, G.; Hamze, A.; Messaoudi, S.;
Provot, O.; Le Calvez, P.-B.; Brion, J.-D.; Alami, M.
Synthesis 2008, 1607. (c) Kim, S.; Yamamoto, K.; Hayashi,
K.; Chiba, K. Tetrahedron 2008, 64, 2855. (d) Hellal, M.;
Bourguignon, J.-J.; Bihel, F. J.-J. Tetrahedron Lett. 2008,
49, 62. (e) Marchal, E.; Uriac, P.; Legouin, B.; Toupet, L.;
van de Weghe, P. Tetrahedron 2007, 63, 9979.
(f) Kanazawa, C.; Terada, M. Tetrahedron Lett. 2007, 48,
933. (g) Uchiyama, M.; Ozawa, H.; Takuma, K.;
Matsumoto, Y.; Yonehara, M.; Hiroya, K.; Sakamoto, T.
Org. Lett. 2006, 8, 5517.
(5) (a) Baldwin, J. E.; Thomas, R. C.; Kruse, L. I.; Silberman, L.
J. Org. Chem. 1977, 42, 3846. (b) Johnson, C. D. Acc.
Chem. Res. 1993, 26, 476.
(6) (a) Reboredo, F. J.; Treus, M.; Estevez, J. C.; Castedo, L.;
Estevez, R. J. Synlett 2002, 999. (b) Uchiyama, M.; Ozawa,
H.; Takuma, K.; Matsumoto, Y.; Yonehara, M.; Hiroya, K.;
Sakamoto, T. Org. Lett. 2006, 24, 5517. (c) Marchal, E.;
Uriac, P.; Legouin, B.; Toupet, L.; van de Weghe, P.
Tetrahedron 2007, 63, 9979. (d) Brady, M. G. A.; Kariuki,
B.; Knight, D. W.; Mohammed, F. K. Tetrahedron Lett.
2009, 50, 1385.
(7) Yu, Y.; Stephenson, A.; Mitchell, D. Tetrahedron Lett.
2006, 47, 3811.
(8) For our contributions on these targets, see: (a) Fernandez,
M.; Barcia, C.; Estevez, J. C.; Estevez, R. J.; Castedo, L.
Synlett 2004, 267. (b) Barcia, J. C.; Cruces, J.; Estevez, J. C.;
Estevez, R. J.; Castedo, L. Tetrahedron Lett. 2002, 43,
5141. (c) Cruces, J.; Martinez, E.; Treus, M.; Martinez,
Synlett 2009, No. 19, 3107–3110 © Thieme Stuttgart · New York